Otamixaban in acute coronary syndromes.
Eikelboom
John W
JW
Thrombosis Service, Hamilton General Hospital, Hamilton, ON, Canada L8L 2X2. eikelbj@mcmaster.ca
Weitz
Jeffrey I
JI
D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use; D017322:Clinical Trials, Phase II as Topic; D003497:Cyclic N-Oxides / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D016903:Drug Monitoring; D006493:Heparin / Q000627:therapeutic use; D006629:Hirudins; D006801:Humans; D008657:Metabolic Clearance Rate; D018579:Patient Selection; D010446:Peptide Fragments / Q000627:therapeutic use; D011725:Pyridines / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000925:Anticoagulants; D003497:Cyclic N-Oxides; D006629:Hirudins; D010446:Peptide Fragments; D011725:Pyridines; D011994:Recombinant Proteins; D006493:Heparin; C435830:otamixaban; C074619:bivalirudin